In a special podcast interview with BioCentury’s Editor in Chief Simone Fishburn, James Sabry, Global Head of Pharma Partnering at Roche and Mike Gilman CEO of Arrakis discuss consummating this deal while under lockdown of COVID-19.

Special Report: Consummating a deal under lockdown

<p>BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.<br><br>For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.</p>

Business

Science

Life Sciences

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

Share Special Report: Consummating a deal under lockdown

Sign up to save your podcasts

Special Report: Consummating a deal under lockdown

Special Report: Consummating a deal under lockdown

More shows like BioCentury This Week

a16z Podcast

The Bio Report

Exchanges

Odd Lots

The Readout Loud

The Peter Attia Drive

Becker’s Healthcare Podcast

Tradeoffs

Biotech 2050 Podcast

Business Of Biotech

Biotech Hangout

The Top Line

BG2Pod with Brad Gerstner and Bill Gurley

Ground Truths

The BioCentury Show